Centessa Pharmaceuticals (CNTA) Depreciation and Depletion (2022 - 2024)
Centessa Pharmaceuticals (CNTA) has disclosed Depreciation and Depletion for 3 consecutive years, with $48000.0 as the latest value for Q4 2024.
- Quarterly Depreciation and Depletion fell 47.83% to $48000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2024, changed 0.0% year-over-year, with the annual reading at $300000.0 for FY2025, 0.0% changed from the prior year.
- Depreciation and Depletion for Q4 2024 was $48000.0 at Centessa Pharmaceuticals, down from $82000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $92000.0 in Q4 2023, with the low at $28000.0 in Q1 2022.
- Average Depreciation and Depletion over 3 years is $60916.7, with a median of $65000.0 recorded in 2024.
- The sharpest move saw Depreciation and Depletion skyrocketed 162.5% in 2023, then crashed 47.83% in 2024.
- Over 3 years, Depreciation and Depletion stood at $36000.0 in 2022, then surged by 155.56% to $92000.0 in 2023, then plummeted by 47.83% to $48000.0 in 2024.
- According to Business Quant data, Depreciation and Depletion over the past three periods came in at $48000.0, $82000.0, and $84000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.